Production of cancer medications set to begin in Kazakhstan this year

Production of cancer medications set to begin in Kazakhstan this year

Kazakhstan is set to commence producing cancer drugs as early as this year. Roche’s cancer treatment medications are scheduled for production at the Nobel Almaty Pharmaceutical Factory in the second half of 2024. Additionally, plans are in place to produce Pfizer’s pneumococcal conjugate vaccine Prevnar 20, according to the country’s Health Ministry. The start date for project implementation will be determined by a special investment agreement. Furthermore, initiatives with pharmaceutical company Big Pharma and other investors from the U.S., Switzerland, South Korea, Turkey, Germany, and Japan are in various stages of progress. Their implementation will facilitate obtaining innovative medicines and ensure the free use of modern medical equipment in Kazakhstan.